Back to VRTX
BENDER ROBERT & ASSOCIATES → VRTX
BENDER ROBERT & ASSOCIATES VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
5
Latest value
$13.9M
Q3 2026
Peak value
$13.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $10.3M |
| Q4 2025 | $12M |
| Q1 2026 | $11.7M |
| Q2 2026 | $13.1M |
| Q3 2026 | $13.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $13.9M | 26.7K | — | — |
| Q2 2026 | $13.1M | 26.3K | — | — |
| Q1 2026 | $11.7M | 26.2K | — | — |
| Q4 2025 | $12M | 26.5K | — | — |
| Q3 2025 | $10.3M | 26.3K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B